NCIRE - The Veterans Health Research Institute Home  |  Sitemap  |  Intranet  

Give Now
About NCIRE Support Our Mission Careers at NCIRE Contact Us The NCIRE Community - Researchers at Work
About NCIRE - The Veterans Health Research Institute
NCIRE's Impact on Veterans Veteran's Health Research Researchers by Name
There's no question that the San Francisco VA Medical Center, with the support of NCIRE, plays a major role in advancing veterans health care through research. The excellence of our NCIRE and SFVAMC investigators, all of whom are UC San Francisco faculty members, is fundamental to our success in developing cutting edge knowledge that will advance medical treatments of veterans and others, both locally and worldwide.

Paul Volberding, MD
Chair, NCIRE Board of Directors
Chief of Medicine, SFVAMC

Contact Us
Inquire Online
Email NCIRE
Give Now
Conrad C. Alano, PhD

Research Scientist, Neurology Service, SFVAMC
Assistant Adjunct Professor of Neurology, UCSF

Email: conrad.alano@va.gov

Mitochondria Mediate the Life and Death of Cells

Although tremendous progress has been made in the treatment of cerebrovascular disease, stroke remains a leading cause of death and severe disability in the United States.  The mechanisms proposed in many diseases and injuries that lead to the death of brain cells include oxidative free radical damage and mitochondrial dysfunction. Neuronal death resulting from ischemic stroke is caused by a sequence of events initiated by ischemia (interruption of blood supply to cells) and reperfusion (resumption of blood supply).  Dr. Alano's recent studies suggest that 1) ischemic injury is mediated by free radical damage, 2) free radicals decrease mitochondrial function, 3) mitochondrial dysfunction is associated with bioenergetic failure, and 4) collapse of bioenergetic homeostasis is a major factor mediating ischemic neuronal death. Dr. Alano and his colleagues propose to establish the foundation of characterizing the mechanisms involved in mitochondrial dysfunction and bioenergetic failure, determine the efficacy of known and novel compounds for treatment for these conditions, and ultimately translate this knowledge into clinical practice.

Alano CC, Kauppinen TM, Valls AV, Swanson RA. 2006. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103(25):9685-90.

Alano CC, Tran A, Tao R, Ying W, Karliner JS, Swanson RA. 2007. Differences among cell types in NAD+ compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J Neurosci R 85(15):3378-85.